Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-14 Purchase |
2025-03-18 6:59 pm |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
175,000 | $0.6068 | $106,190 | 712,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-10 Option Award |
2025-02-26 7:33 pm |
N/A 2035-02-09 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
1,856,250 | $0 | 2,056,250 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 5:35 pm |
N/A 2034-06-12 |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
6,812 | $0 | 17,824 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 8:17 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-11-16 Option Award |
2023-11-20 8:53 pm |
N/A 2032-12-14 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
7,500,000 | $0 | 7,500,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 7:06 pm |
N/A 2033-06-21 |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
7,900 | $0 | 16,312 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:20 pm |
N/A 2032-12-14 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
7,500,000 | $0 | 7,500,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-30 9:52 pm |
N/A 2032-06-21 |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
7,900 | $0 | 13,712 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:16 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn Director |
65,000 | $0 | 65,000 (Direct) |
View |
Ownership |
2021-06-16 7:23 pm |
N/A 2031-05-19 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn Director |
0 | $0 | 400,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 4:16 pm |
N/A 2031-06-02 |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
6,750 | $0 | 10,312 (Direct) |
View |
| 2020-06-24 Option Award |
2020-06-26 4:09 pm |
N/A 2030-06-24 |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
6,750 | $0 | 8,062 (Direct) |
View |
| 2020-06-19 Exercise |
2020-06-23 4:14 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Seely Lynn Director |
1,312 | $0 | 1,312 (Direct) |
View |